| TCGA | CGGA | ||||||
---|---|---|---|---|---|---|---|---|
Variables | Total (n=146) | High group (n=100) | Low group (n=46) | p | Total (n=173) | High group (n=38) | Low group (n=135) | p |
Age | Â | Â | Â | 0.606 | Â | Â | Â | 0.325 |
 <60 | 70 (48%) | 46 (46%) | 24 (52%) |  | 114 (66%) | 22 (58%) | 92 (68%) |  |
 ≥60 | 76 (52%) | 54 (54%) | 22 (48%) |  | 59 (34%) | 16 (42%) | 43 (32%) |  |
Sex | Â | Â | Â | 0.236 | Â | Â | Â | 0.589 |
 Female | 53 (36) | 40 (40%) | 13 (28%) |  | 68 (39%) | 13 (34%) | 55 (41%) |  |
 Male | 93 (64) | 60 (60%) | 33 (72%) |  | 105 (61%) | 25 (66%) | 80 (59%) |  |
Radiation | Â | Â | Â | 0.918 | Â | Â | Â | 0.298 |
 NO | 20 (14%) | 13 (13%) | 7 (15%) |  | 25 (14%) | 3 (8%) | 22 (16%) |  |
 YES | 126 (86%) | 87 (87%) | 39 (85%) |  | 148 (86%) | 35 (92%) | 113 (84%) |  |
Chemotherapy | Â | Â | Â | 0.524 | Â | Â | Â | 0.016 |
 NO | 35 (24%) | 26 (26%) | 9 (20%) |  | 37 (21%) | 14 (37%) | 23 (17%) |  |
 YES | 111 (76%) | 74 (74%) | 37 (80%) |  | 136 (79%) | 24 (63%) | 112 (83%) |  |
MGMT promoter | Â | Â | Â | 0.593 | Â | Â | Â | 0.248 |
 Methylated | 51 (35%) | 33 (33%) | 18 (39%) |  | 71 (41%) | 12 (32%) | 59 (44%) |  |
 Un-methylated/Unknown | 95 (65%) | 67 (67%) | 28 (61%) |  | 102 (59%) | 26 (68%) | 76 (56%) |  |
TERT promoter | Â | Â | Â | 0.008 | Â | Â | Â | - |
 Mutant | 41 (28%) | 21 (21%) | 20 (43%) |  | - | - | - |  |
 Unknown | 103 (71%) | 78 (78%) | 25 (54%) |  | - | - | - |  |
 WT | 2 (1%) | 1 (1%) | 1 (2%) |  | - | - | - |  |
KPS | Â | Â | Â | 0.025 | Â | Â | Â | - |
 <70 | 25 (17%) | 22 (22%) | 3 (7%) |  | - | - | - |  |
 ≥70 | 88 (60%) | 60 (60%) | 28 (61%) |  | - | - | - |  |
 Unknown | 33 (23%) | 18 (18%) | 15 (33%) |  | - | - | - |  |
Group | Â | Â | Â | <0.001 | Â | Â | Â | - |
 histoGBM | 113 (77%) | 89 (89%) | 24 (52%) |  | - | - | - |  |
 molGBM | 33 (23%) | 11 (11%) | 22 (48%) |  | - | - | - |  |